Reverse Remodeling of the Myocardial Extracellular Matrix After Prolonged Left Ventricular Assist Device Support Follows a Biphasic Pattern

Journal of Heart and Lung Transplantation

Volumn 25, Issue 9, 2006, Pages 1091-1098

  Bruggink, Annette H ^a   van Oosterhout, Matthijs F M ^a   de Jonge, Nicolaas ^a   Ivangh, Bas ^a   van Kuik, Joyce ^a   Voorbij, Ron H A M ^a   Cleutjens, Jack P M ^b   Gmelig Meyling, Frits H J ^a   de Weger, Roel A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; MESSENGER RNA;

ADULT; ARTICLE; ASSAY; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; STAINING;

ADOLESCENT; ADULT; COLLAGEN TYPE I; COLLAGEN TYPE III; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HEART; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PERIODICITY; PROTEOGLYCANS; RNA, MESSENGER; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33748180147     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.05.011     Document Type: Article

References (38)

1. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. JAMA 13 (1989) 1637-1652
2. Kemperman H., van den Berg M., Kirkels H., and de Jonge N. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem 50 (2004) 1670-1672
3. Bruggink A.H., de Jonge N., van Oosterhout M.F., et al. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. J Heart Lung Transplant 25 (2006) 174-180
4. de Jonge N., van Wichen D.F., van Kuik J., et al. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. J Heart Lung Transplant 22 (2003) 1028-1036
5. Zafeiridis A., Jeevanandam V., Houser S.R., and Margulies K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
6. Levin H.R., Oz M.C., Chen J.M., Packer M., Rose E.A., and Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 91 (1995) 2717-2720
7. de Jonge N., van Wichen D.F., Schipper M.E., et al. Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments. JAMA 39 (2002) 963-969
8. de Jonge N., Kirkels H., Lahpor J.R., et al. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?. JAMA 37 (2001) 1794-1799
9. Rodrigue-Way A., Burkhoff D., Geesaman B.J., et al. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant 24 (2005) 73-80
10. Barbone A., Holmes J.W., Heerdt P.M., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 104 (2001) 670-675
11. Nakatani S., McCarthy P.M., Kottke-Marchant K., et al. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. JAMA 27 (1996) 894-901
12. Madigan J.D., Barbone A., Choudhri A.F., et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 121 (2001) 902-908
13. McCarthy P.M., Nakatani S., Vargo R., et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 59 (1995) 609-613
14. Klotz S., Naka Y., Oz M.C., and Burkhoff D. Biventricular assist device-induced right ventricular reverse structural and functional remodeling. J Heart Lung Transplant 24 (2005) 1195-1201
15. Muller J., Wallukat G., Weng Y.G., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96 (1997) 542-549
16. Bruckner B.A., Stetson S.J., Perez-Verdia A., et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 20 (2001) 457-464
17. Ottani V., and Raspanti M. Ruggeri A. Collagen structure and functional implications. Micron 32 (2001) 251-260
18. de Souza R.R. Aging of myocardial collagen. Biogerontology 3 (2002) 325-335
19. Cleutjens J.P., Verluyten M.J., Smiths J.F., and Daemen M.J. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 147 (1995) 325-338
20. Diez J., Panizo A., Gil M.J., Monreal I., Hernandez M., and Pardo Mindan J. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis. Circulation 93 (1996) 1026-1032
21. Alla F., Kearney-Schwartz A., Radauceanu A., Das Dores S., Dousset B., and Zannad F. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes. Eur J Heart Fail 8 (2006) 147-153
22. Laviades C., Varo N., Fernandez J., et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 98 (1998) 535-540
23. Klappacher G., Franzen P., Haab D., et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 75 (1995) 913-918
24. Host N.B., Jensen L.T., Bendixen P.M., Jensen S.E., Koldkjaer O.G., and Simonsen E.E. The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction. Am J Cardiol 76 (1995) 869-873
25. Uusimaa P., Risteli J., Niemela M., et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 96 (1997) 2565-2572
26. Diez J., Laviades C., Mayor G., Gil M.J., and Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 91 (1995) 1450-1456
27. Miller E.J., and Rhodes R.K. Preparation and characterization of the different types of collagen. Meth Enzymol 82 (1982) 33-64
28. Chiariello M., Ambrosio G., Cappelli-Bigazzi M., Perrone-Filardi P., Brigante F., and Sifola C. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J Mol Cell Cardiol 18 (1986) 283-290
29. Li Y.Y., Feng Y., McTiernan C.F., et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 104 (2001) 1147-1152
30. Milting H., Jacob M., Kassner A., et al. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling. J Heart Lung Transplant 23 (2004) 396-404
31. Klotz S., Foronjy R.F., Dickstein M.L., et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 112 (2005) 364-374
32. Lombardi R., Betocchi S., Losi M.A., et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108 (2003) 1455-1460
33. Schwartzkopff B., Fassbach M., Pelzer B., Brehm M., and Strauer B.E. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. Eur J Heart Fail 4 (2002) 439-444
34. Velling T., Risteli J., Wennerberg K., Mosher D.F., and Johansson S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem 277 (2002) 37377-37381
35. Frazier O.H., Benedict C.R., Radovancevic B., et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 62 (1996) 675-681
36. Weber K.T. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 96 (1997) 4065-4082
37. Yu C.M., Tipoe G.L., Wing-Hon Lai K., and Lau C.P. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. JAMA 38 (2001) 1207-1215
38. Scheinin S.A., Capek P., Radovancevic B., Duncan J.M., McAllister Jr. H.A., and Frazier O.H. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J 38 (1992) M271-M274